Verrica Pharmaceuticals (VRCA)

• Market cap: $77M
• 1 day: -7.95%
• 5 days: 11.25%
• 1 month: 109.56%
• 3 months: 60.28%
• 6 months: 32.52%
• Year to date: 15.36%
• 1 year: -14.63%
• 5 years: -92.16%
• 10 years: -95.37%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71